A new study has shown that the inexpensive drug digoxin, also known as digitalis, can cut the risk of rehospitalization in heart failure patients by more than 30 percent.
During the study, researchers reexamined the results of a 1997 study that concluded that digoxin did not lower death rates. They found that while it might not lower death rates, it did make patients 34 percent less likely to be admitted to a hospital within 30 days. Half of the members of the trial group were 65 years or older.
The researchers are now seeking to replicate the results in a modern study.
To learn more, click here.
0 comments:
Post a Comment